Epigenetic reprogramming of tissue-resident memory T cells in chronic inflammatory disorde
by Chen Ling·Updated 2d ago
1020.8 KB7files
Available on 1 platform
Sign in to view source links and access this dataset
Description
124 patients with rheumatoid arthritis, inflammatory bowel disease, or psoriasis and 35 healthy controls contributed samples for this integrative multi-omics atlas. The dataset includes results from scATAC-seq, ChIP-seq, whole-genome bisulfite sequencing, and scRNA-seq, identifying 847 differentially methylated regions and 1,239 altered chromatin accessibility peaks. Chen Ling published the dataset on figshare in 2026, revealing tissue-specific epigenetic vulnerabilities and potential therapeutic targets like DNMT1 and EZH2.
Use Cases
Train machine learning classifiers to distinguish pathogenic from protective T cell states based on the described multi-omics features.
Analyze tissue-specific epigenetic defects, such as FOXP3 hypermethylation in intestinal TRM cells or elevated H3K27me3 in synovial TRM cells.
Investigate the role of TET2-mediated demethylation at pro-inflammatory enhancers for cytokines like IL-17A and TNF.
Validate potential drug targets (e.g., DNMT1, EZH2) by modeling their inhibition effects on epigenetic reprogramming.
Strengths
Includes multi-omics data from 159 total samples (124 patients, 35 controls) across three distinct chronic inflammatory diseases.
Reports specific, quantified epigenetic changes, including 847 differentially methylated regions and methylation percentage changes (e.g., -87.3% for TNF).
Cell samples had high purity (>92%) and viability (>94%), and a machine learning model achieved 94.2% accuracy for cell classification.
Limitations
The primary data files are listed as JPG format (1020.8 KB), which suggests the dataset may contain summary figures or plots rather than the raw multi-omics data tables.
Row count and column-level documentation are unknown, limiting assessment of the dataset's structure and granularity.
The authors note limitations include an ex vivo validation system and the need for larger multicentric studies to validate biomarkers.
Provenance
Source
figshare, author Chen Ling.
Collection Method
Integrative multi-omics analysis (scATAC-seq, ChIP-seq, whole-genome bisulfite sequencing, scRNA-seq) of purified TRM cells from patient and control samples.
Freshness
Last updated 2026-06-03 11:02:20.
License is CC-BY-4.0. The listed file format (JPG) and small size (1020.8 KB) indicate this is likely a summary figure or poster, not the primary multi-omics data tables.